11 research outputs found

    20 Jahre ‚Gäa e.V. - Vereinigung ökologischer Landbau’

    Get PDF
    For the understanding of ecological agriculture, knowledge of its roots is essential. Actual literature about this topic does not cover the history of ecological agriculture in East Germany especially if chronological development and individual motivation are seen as mutual dependent. The ecological organisation Gäa e.V. was founded in the GDR in 1989. Its origins were oppositional environmental groups working within the East German church. It developed own principles based on individual experience with unique aspects. It has established and integrated well in the German ecological agriculture structure after the reunification and the changed political background as an authentic representative of and for the East German ecological agriculture scene

    Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

    Get PDF
    Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis which drives endothelial cell survival, proliferation, and migration while increasing vascular permeability. Playing an important role in the physiology of normal ovaries, VEGF has also been implicated in the pathogenesis of ovarian cancer. Essentially by promoting tumor angiogenesis and enhancing vascular permeability, VEGF contributes to the development of peritoneal carcinomatosis associated with malignant ascites formation, the characteristic feature of advanced ovarian cancer at diagnosis. In both experimental and clinical studies, VEGF levels have been inversely correlated with survival. Moreover, VEGF inhibition has been shown to inhibit tumor growth and ascites production and to suppress tumor invasion and metastasis. These findings have laid the basis for the clinical evaluation of agents targeting VEGF signaling pathway in patients with ovarian cancer. In this review, we will focus on VEGF involvement in the pathophysiology of ovarian cancer and its contribution to the disease progression and dissemination

    Cell–cell and cell–matrix dynamics in intraperitoneal cancer metastasis

    Get PDF
    The peritoneal metastatic route of cancer dissemination is shared by cancers of the ovary and gastrointestinal tract. Once initiated, peritoneal metastasis typically proceeds rapidly in a feed-forward manner. Several factors contribute to this efficient progression. In peritoneal metastasis, cancer cells exfoliate into the peritoneal fluid and spread locally, transported by peritoneal fluid. Inflammatory cytokines released by tumor and immune cells compromise the protective, anti-adhesive mesothelial cell layer that lines the peritoneal cavity, exposing the underlying extracellular matrix to which cancer cells readily attach. The peritoneum is further rendered receptive to metastatic implantation and growth by myofibroblastic cell behaviors also stimulated by inflammatory cytokines. Individual cancer cells suspended in peritoneal fluid can aggregate to form multicellular spheroids. This cellular arrangement imparts resistance to anoikis, apoptosis, and chemotherapeutics. Emerging evidence indicates that compact spheroid formation is preferentially accomplished by cancer cells with high invasive capacity and contractile behaviors. This review focuses on the pathological alterations to the peritoneum and the properties of cancer cells that in combination drive peritoneal metastasis

    Entomopathogenic Fungi for Control of Bemisia tabaci Biotype B: Foreign Exploration, Research and Implementation

    No full text

    New functions for the matrix metalloproteinases in cancer progression

    No full text
    Matrix metalloproteinases (MMPs) have long been associated with cancer-cell invasion and metastasis. This provided the rationale for clinical trials of MMP inhibitors, unfortunately with disappointing results. We now know, however, that the MMPs have functions other than promotion of invasion, have substrates other than components of the extracellular matrix, and that they function before invasion in the development of cancer. With this knowledge in hand, can we rethink the use of MMP inhibitors in the clinic

    Metastasis Initiation

    No full text
    corecore